Levonorgestrel, Pharmacokinetics, Efficacy and Safety 65[45] Palomino WA, Kohen P, Devoto L. A single midcycle dose of
levonorgestrel similar to emergency contraceptive does not alter the
expression of the l-selectin ligand or molecular markers of endometrial
receptivity. Fertil Steril. 2010;94:1589–1594.
[46] Meng CX, Andersson KL, Bentin-Ley U, Gemzell-Danielsson K,
Lalitkumar PG. Effect of levonorgestrel and mifepristone on endometrial
receptivity markers in a three-dimensional human endometrial cell
culture model. Fertil Steril. 2009;91: 256–264.
[47] Lalitkumar PG, Lalitkumar S, Meng CX, Stavreus-Evers A, Hambiliki
F, Bentin-Ley U, Kristina Gemzell-Danielsson K. Mifepristone, but not
levonorgestrel, inhibits human blastocyst attachment to an in vitro
endometrial three-dimensional cell culture model. Hum Reprod.
2007;22:3031–3037.
[48] Noe G, Croxatto HB, Salvatierra AM, Reyes V, Villarroel C, Muñoz C,
Morales G, Retamales A. Contraceptive efficacy of emergency
contraception with levonorgestrel given before or after ovulation.
Contraception, 2010;81:414–420.
[49] Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser IS.
Effectiveness of levonorgestrel emergency contraception given before or
after ovulation — a pilot study. Contraception. 2007;75: 112–118.
[50] Gemzell-Danielsson K. Mechanism of action of emergency
contraception. Contraception. 2010; 82: 404–409.
[51] Noé G, Croxatto HB, Salvatierra AM, Reyes V, Villarroel C, Muñoz C,
Morales G, Retamales A. Contraceptive efficacy of emergency
contraception with levonorgestrel given before or after ovulation
Contraception. 2011;84:486-492.
[52] Sivin I. Risks and benefits, advantages and disadvantages of
levonorgestrel-releasing contraceptive implants. Drug Saf. 2003;26:303-
335.
[53] Power J, French R, Cowan F. Subdermal implantable contraceptives
versus other forms of reversible contraceptives or other implants as
effective methods of preventing pregnancy. Cochrane Database Syst
Rev. 2007;3:CD001326.
[54] ESHRE Capri Workshop Group. Intrauterine devices and intrauterine
systems. Hum Reprod Update. 2008; 14:197-208.
[55] Lahteenmaki P, Rauramo I, Backman T. The levonorgestrel intrauterine
system in contraception. Steroids. 2000;65:693–697.
[56] Thonneau PF, Almont T. Contraceptive efficacy of intrauterine devices.
Am J Obstet Gynecol. 2008; 198:248–253.